Latest Posts

First court case for Drug Patent Linkage
11.30.2021

China : First court case for Drug Patent Linkage

The Japanese drug manufacturer Chugai Pharmaceutical sued a local China company for patent infringement at the IP court in Beijing, China, seeking to stay the government approval process for marketing a generic drug of the Eldecalcitol same effect.

It is the first case after China regulating the Article 76 of the 4th Amendment of Patent Law effective 1 June 2021, whereby a “dual track” early resolution mechanism is implemented for resolving drug patent disputes during the government approval process of marketing generic drugs. The Beijing IP Court is one of the 2 venues for the Article 76 proceedings, the other venue is the CNIPA (Patent Office).

Benny Kong & Tsai © 2021
 

Benny Kong & Tsai, Solicitors

Free eNewsletter Subscription


    Company Name

    Contact

    Email

    Free Trademark Webinar Invitation

    Language : Cantonese
    Time: 29 Sep 2021 (Wednesday) 3:30 pm - 4:30 pm
    Contact : (852) 3105 5100 / enquiry@bk.com.hk

      Application form
      Name

      Company Name

      Position

      Email

      Tel

      Number of participant(s)

      Benny Kong & Tsai, LLP
      Unit 19B, Overseas Trust Bank Building, No. 160 Gloucester Road, Hong Kong
      telephone:(852) 3105 5100
      email: enquiry@bk.com.hk

      Copyright ©2022 BKT.hk All rights reserved.